COMMUNIQUÉS West-GlobeNewswire

Kura Oncology Identifies Farnesylated Proteins Associated with CXCL12 Expression, Potential Biomarker of Clinical Benefit from Tipifarnib in Lymphoma Indications
02/04/2019
– Tipifarnib is a farnesyl transferase inhibitor that downregulates CXCL12 – – Gene expression of the exclusively farnesylated RHOE and PRICKLE2 proteins associated with CXCL12 expression – – Pre-treatment tumor CXCL12 [...]
Cara Therapeutics to Present at the 18th Annual Needham Healthcare Conference
02/04/2019
STAMFORD, Conn., April 02, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on the [...]
Agios Announces New Commercial Leadership Structure
02/04/2019
Darrin Miles Appointed Senior Vice President, U.S. Commercial & Global Marketing; Previously Served as Vice President, Oncology Program Leadership at Agios Search Initiated for Senior Vice President, International [...]
Gritstone Oncology Presents Data at AACR Demonstrating MHC Class II Neoantigen Prediction with EDGE™ Significantly Outperforms Current Prediction Methods
02/04/2019
EMERYVILLE, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
BriaCell Announces Clinical Trial Collaboration Agreement with Incyte
02/04/2019
BriaCell Therapeutics and Incyte have formed a non-exclusive clinical trial collaboration to evaluate the effects of combinations of novel clinical candidates Under the agreement, Incyte will provide compounds from its [...]
Taconic Biosciences reçoit une licence pour le microbiote intestinal de souris sauvages du National Institute of Diabetes and Digestive and Kidney Diseases
02/04/2019
RENSSELAER, New York, 02 avr. 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, un chef de file mondial dans la fourniture de modèles de rongeurs génétiquement modifiés, annonce qu'elle a reçu une licence pour le microbiote [...]
Allovate Therapeutics Appoints Bob Pomrenke as CEO
02/04/2019
New York, April 02, 2019 (GLOBE NEWSWIRE) -- Allovate Therapeutics (“Allovate ® ”), a New York-based biotechnology company focused on improving treatment for allergies, is pleased to announce the appointment of Robert " [...]
Cansortium: Multi-State Cannabis Operator Trading on CSE -- CFN Media
02/04/2019
SEATTLE, April 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication [...]
Jounce Therapeutics Reports Improved PFS and OS Associated with Vopratelimab (JTX-2011) Treatment Emergent Biomarker at the 2019 American Association for Cancer Research (AACR) Annual Meeting
02/04/2019
- Improved PFS and OS observed in patients treated with vopratelimab who have emergence of ICOS hi CD4 T cells compared to patients with ICOS lo CD4 T cells - - ICOS hi CD4 T cells demonstrate distinct, activated T [...]
Genocea Presents Data at AACR 2019 Supporting Utility of ATLAS™ Platform in Predicting Melanoma Patient Response to Immune Checkpoint Inhibitors
02/04/2019
CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing neoantigen cancer immunotherapies, today announced the presentation of data from [...]
Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGFβ1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination Therapy
02/04/2019
Preclinical data presented at the American Association for Cancer Research annual meeting provide further support for the potential of SRK-181 to overcome primary resistance to checkpoint blockade therapy (CBT) TGFβ1- [...]
Dynavax Presents Phase 1b Data on Inhaled DV281 TLR9 Agonist at the 2019 AACR Annual Meeting
02/04/2019
Using an investigational safety treatment regimen, inhaled DV281 in combination with systemic nivolumab was well tolerated in a population of heavily pre-treated NSCLC patients Target engagement was observed at all dose [...]
Maple Leaf Green World Inc. Announces Filing of 2018 Audited Annual Financial Statements and Management Discussion & Analysis and Provides a Corporate Update
02/04/2019
CALGARY, Alberta, April 02, 2019 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) has filed its 2018 audited annual financial statements and related [...]
Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pre-clinical in vivo models of lung cancer
02/04/2019
Data presented at AACR Annual Meeting 2019 In vivo study conducted alone or in collaboration with The University of Texas MD Anderson Cancer Center demonstrated: NBTXR3 in combination with a PD-1 inhibitor enhanced an [...]
Efficacité de la combinaison NBTXR3 (premier produit de sa classe), radiothérapie et immunothérapie avec anti-PD-1 démontrée dans le cancer du Poumon résistant dans des modèles précliniques in vivo
02/04/2019
Efficacité de la combinaison NBTXR3 (premier produit de sa classe), radiothérapie et immunothérapie avec anti-PD-1 démontrée dans le cancer du Poumon résistant dans des modèles précliniques in vivo Données présentées au [...]
Molina Healthcare Announces First Quarter 2019 Earnings Release and Conference Call Dates
02/04/2019
LONG BEACH, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the first quarter ended March 31, 2019. Molina Healthcare will issue [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
02/04/2019
Company Announcement Copenhagen, Denmark; April 2, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 146,961 shares as a consequence of the exercise of employee warrants. The increase is [...]
SuperSonic Imagine to Highlight Breast Ultrasound Imaging with Aixplorer® MACH 30 at SBI/ACR Breast Imaging Symposium
02/04/2019
Hollywood, Florida, April 4-7, 2019 Visit Supersonic Imagine at Booth # 208 AIX-EN-PROVENCE, France, April 02, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specialising in medical [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2019
02/04/2019
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2019 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

Pages